SACGHS membership
This article was originally published in The Gray Sheet
Executive Summary
Recently chartered Secretary's Advisory Committee on Genetics, Health & Society will be chaired by Edward McCabe, MD/PhD, University of California-Los Angeles/Mattel Children's Hospital, HHS announces Dec. 23. A pediatrician, McCabe previously chaired the Secretary's Advisory Committee on Genetic Testing, whose original mission statement was expanded to create SACGHS (1"The Gray Sheet" Oct. 28, 2002, p. 9). The 13-member committee comprises biomedical researchers, ethicists and patient advocates, among others. Along with McCabe, two members from SACGT have been retained: Attorney Cynthia Berry and Reed Tuckson, MD. New SACGHS panelists include Eric Lander, PhD, director of the Whitehead Institute for Genome Research; Emily Winn-Deen, PhD, genomics business director for Roche Molecular Systems and a former Celera Genomics executive; and Huntington Willard, PhD, incoming director of the Institute for Genome Sciences and Policy at Duke University...
You may also be interested in...
HHS Genetics Panel Replaces SACGT; Thompson Defends Membership Rules
HHS' reconfigured panel on genetics policy places less focus on genetic test regulation than its predecessor, the Secretary's Advisory Committee on Genetic Testing
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.